Navigation Links
In the Case of Epilepsy, Generic Drugs and Random Product Substitution are Not Always "Good Medicine"
Date:5/27/2009

Nisola LLC launches campaign for stricter regulatory approval requirements and continuity of product supply.

New York, NY (PRWEB) May 27, 2009 -- A recent report released by Wolters Kluwer Health predicts that by the end of the year, nearly two-thirds of all drug prescriptions will be filled with generic drugs. This march to generics is fueled by several factors, which include the current economy, ever-increasing co-payment requirements for brand name drugs and pharmacies' desire to increase their profits by filling prescriptions with high margin generics versus lower margin brand name medicines.

This reliance on generics is generally considered a positive shift in healthcare as the vast majority of patients see significant cost savings without any noticeable change in their treatment. However, in the case of many neurological disorders, especially epilepsy, switching from a brand to a generic or between generics can be extremely dangerous.

The primary problem with random product substitution is that the Food and Drug Administration (FDA) does not require generic drugs to definitively demonstrate therapeutic equivalence to their brand name counterparts (i.e., the same clinical efficacy and safety profile). In fact, for approval, the FDA only requires that the generic be bioequivalent (i.e., within a certain range of a brand name drug's potency as measured by single-dose blood tests in healthy volunteers). Additionally, pharmacies, in their quest for profits, not only push patients to switch from brand name drugs to generics, but often switch from one generic manufacturer to another. Most alarmingly from an epilepsy patient's perspective, this means that one can receive a different generic brand every time they refill their prescriptions. This is understandably a nightmare for a patient trying to regulate their medications to avoid both seizures and/or side effects.

&qu
'/>"/>

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Mutant gene causes epilepsy, intellectual disability in women
2. Novel Techniques Offers New Freedom to Patients with Parkinson's Disease, Epilepsy, Dystonia, and Tremor
3. Guidelines: Pregnancy Safe with Epilepsy, but Valproate Should be Avoided
4. GPhAs 2007 Annual Policy Conference Features Top Generic Industry CEOs; FDA, Government Officials; Wall Street Analysts
5. Mylan Commences Tender Offers and Consent Solicitations for Its 5.750% Senior Notes Due 2010 and 6.375% Senior Notes Due 2015 in Connection With Its Proposed Acquisition of Mercks Generic Pharmaceutical Business
6. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
7. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Adipex-P(R)
8. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Coreg(R)
9. Generic prostate drug helps find high-risk cancers early
10. Perrigo Confirms Filing for Generic Version of Mucinex(R) and Announcement of Lawsuit by Adams Respiratory
11. Mylan Vice Chairman and CEO Robert J. Coury to Ring NYSE Closing Bell(R) in Celebration of Merck Generics Acquisition
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/16/2014)... Eagan, MN (PRWEB) September 16, 2014 Cliff ... to their team. Kristaleen is the newest dental hygienist to ... Care looks forward to working with her and knows she ... to her patients. , Kristaleen grew up in River Falls, ... Dakota County Technical College in 2003 and practiced dental assisting ...
(Date:9/16/2014)... CO (PRWEB) September 16, 2014 Aspen ... that it has been recognized for its high morale ... Consulting magazine “The Best Small Firms to Work For ... survey annually, with more than 10,000 consultants participating across ... Extensive employee satisfaction surveys were conducted, and firms were ...
(Date:9/16/2014)... therapy as part of breast conservation is the ... positive (HR+) invasive breast cancer. A new study ... shows that combination may not be necessary for ... The results, which Fox Chase researchers presented at ... Meeting on Sunday, September 14, suggest that low-risk ...
(Date:9/16/2014)... York, NY (PRWEB) September 16, 2014 ... children around the world will be honored in New ... Award ( http://www.worldofchildren.org ), the only global recognition and ... , Hailed by the media as the “Nobel ... individuals have each created life-changing programs that benefit children ...
(Date:9/16/2014)... 16, 2014 As part of its ... American Citizens (LULAC) will host the second annual health ... will feature free health screenings for osteoporosis, HIV, and ... glucose and cholesterol levels as well as bone marrow ... children under 6 years old , The event will ...
Breaking Medicine News(10 mins):Health News:Cliff Lake Dental Care Announces Newest Team Member 2Health News:Aspen Advisors Earns Recognition in Consulting Magazine’s "Best Small Firms to Work For" 2Health News:Aspen Advisors Earns Recognition in Consulting Magazine’s "Best Small Firms to Work For" 3Health News:Benefit of endocrine therapy in elderly women with low risk hormone receptor positive breast cancer? 2Health News:Benefit of endocrine therapy in elderly women with low risk hormone receptor positive breast cancer? 3Health News:World of Children® Award Announces 2014 Honorees 2Health News:World of Children® Award Announces 2014 Honorees 3Health News:World of Children® Award Announces 2014 Honorees 4Health News:World of Children® Award Announces 2014 Honorees 5Health News:World of Children® Award Announces 2014 Honorees 6Health News:World of Children® Award Announces 2014 Honorees 7Health News:World of Children® Award Announces 2014 Honorees 8Health News:LULAC Hosts Second Annual Latinos Living Healthy Feria de Salud in Los Angeles 2
... EXTON, Pa., Feb. 13 Kensey Nash Corporation (Nasdaq: ... the Canaccord Adams Musculoskeletal Conference at the University ... 24, 2009.Douglas G. Evans, Kensey Nash,s Chief Operating Officer, ... p.m. (ET). The presentation materials will be available ...
... researcher explains , , FRIDAY, Feb. 13 (HealthDay News) -- ... "number sense," but it,s the use of language to ... much higher levels, says a Duke University expert. , ... at Duke, studies how human adults and infants, lemurs ...
... ATSI ), manufacturer and marketer of state-of-the-art cardiac ... financial results,for the fourth quarter ended December 31, 2008, ... The Company will host a conference call and,webcast on ... (2:00 p.m.,Pacific Time) to discuss its fourth quarter and ...
... following is from Betsy McCaughey, Ph.D., the author of the ... Plan."If Keith Olbermann of MSNBC could defend the ... he wouldn,t be resorting to personal attacks on me. ... (2-12-2009). That,s not true.I am not paid by the ...
... Facilities, especially teaching hospitals, have to do more to promote ... Most hospital patients cannot identify -- by name or role ... study of one urban hospital suggests. , "The majority of ... anybody in charge of their care," said study author Dr. ...
... asset to the global practice of radiologyBOSTON, Feb. ... ), a leader in radiology and medical image ... of Directors member Dr. Phillip Berman passed away ... lung cancer. Dr. Berman was 55 years old.(Logo: ...
Cached Medicine News:Health News:College Kids and Monkeys About Equal on Math 2Health News:ATS Medical Announces Fourth Quarter 2008 Earnings Release Date and Conference Call 2Health News:Invitation to Keith Olbermann 2Health News:Many Hospital Patients Can't ID Their Doctors 2Health News:Many Hospital Patients Can't ID Their Doctors 3Health News:AMICAS Mourns the Passing of Board Member Dr. Phillip Berman 2
(Date:9/16/2014)... Ind. , Sept. 16, 2014   Evana ... of custom, automated assembly and test systems, recently received ... a leading medical device manufacturer. The Evana solution will ... quality and ergonomics, as well as reduce labor. ... automatically fed to Evana,s robotic assembly cell. The robot ...
(Date:9/16/2014)... 16, 2014   Vestagen Technical Textiles, Inc. ... at hospitals. The myComfort™ line of patient apparel is ... that is fluid repellant, breathable and in studies done ... of bacteria on the fabric i . ... the chain of transmission. We want myComfort to be ...
(Date:9/16/2014)... OKLAHOMA CITY , Sept. 16, 2014 ... biopharmaceutical company developing novel orally active drugs ... existing antibiotics, announced today a $1.4 million ... investing arm of life sciences accelerator Accele ... from i2E, Inc., a nationally recognized private ...
Breaking Medicine Technology:Evana Automation to Supply Robotic Assembly Cell to Leading Medical Device Manufacturer 2Evana Automation to Supply Robotic Assembly Cell to Leading Medical Device Manufacturer 3New Vestagen Patient Garments Aim to Minimize Pathogen Transmission Inside Hospitals 2Synereca Pharmaceuticals Announces Financing Led by Accele Venture Partners 2Synereca Pharmaceuticals Announces Financing Led by Accele Venture Partners 3Synereca Pharmaceuticals Announces Financing Led by Accele Venture Partners 4
... Wound Management Technologies, Inc. (OTC Bulletin Board: WNDM), a ... company will actively participate at the Save A Leg, ... in Orlando tomorrow, October 8. , In addition to exhibiting its ... a workshop entitled " The ...
... ACCESS PHARMACEUTICALS, INC . (OTC ... agreement with iMedicor (OTC Bulletin Board: VMCI) for the North ... rinse for the management of oral mucositis and stomatitis caused ... System application, initial introduction of MuGard to the 216,000 selected ...
Cached Medicine Technology:Wound Management to Participate at Save A Leg, Save a Life Foundation National Conference 2Wound Management to Participate at Save A Leg, Save a Life Foundation National Conference 3Access Pharmaceuticals Signs eMarketing Agreement With iMedicor For MuGard(TM) 2Access Pharmaceuticals Signs eMarketing Agreement With iMedicor For MuGard(TM) 3Access Pharmaceuticals Signs eMarketing Agreement With iMedicor For MuGard(TM) 4
... kits that quantitatively measure two important cardiac ... elevated serum or plasma homocysteine level is ... risk factor for cardiovascular disease. And numerous ... elevated levels of Lp(a) with increased risk ...
... Our test menu includes kits that quantitatively ... and lipoprotein (a). An elevated serum or ... a strong and independent risk factor for ... early 1970s have associated elevated levels of ...
... Professional Diagnostics is a leading provider of ... DFA test menu that includes kits for ... well as miscellaneous conjugates and components. Our ... wide assortment of substrates and kit sizes ...
... products for autoimmune testing feature single-well ANA ... as specific reflex tests including dsDNA, and ... (Ro), SS-B (La), Scl-70 and Jo-1. In ... full line of products for Cardiolipins (IgA, ...
Medicine Products: